1–10 of 27 results for inherited retinal disease
Oral Gildeuretinol Acetate 14 mg Capsules Stalled Stargardt Disease Progression: Updates in the TEASE-3 Study
Michael Gorin, MD, PhD
Annual Meeting Talks
2024
BCVA Analysis of Low- or High-Dose MCO-010 Optogenetic Therapy for Retinitis Pigmentosa: FIRST TIME 100-Week TOPLINE Results From a Phase 2b/3 Clinical Trial (RESTORE)
Michael A. Singer, MD
Proliferative Sickle Cell Retinopathy
Niloofar Piri, MD
Retina Image Bank: Images of the Week
2025
Qualitative Analysis of Imaging Features and Predictors of Visual Acuity in ABCA4- and PRPH2-Related Disease
Kenneth C Fan, MD, MBA
Safety and Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 8 Years and 9 Years
Stephen R. Russell, MD
Retinitis Pigmentosa Bullseye Appearing Autofluorescence
Retinitis Pigmentosa with PPRPE
Vishal Agrawal, MD, FRCS,FACS,FASRS
Pericentral Retinitis Pigmentosa
Mauricio Bayram-Suverza, MD
Mark E Pennesi, MD/PhD
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Updates from the Field
North Carolina Macular Dystrophy collage
Kent W. Small, MD
2022